Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma

Biomarkers

Volumn 12, Issue 4, 2007, Pages 403-413

  Krzystek Korpacka, M ^a   Matusiewicz, M ^a   Diakowska, D ^a   Grabowski, K ^a   Blachut, K ^a   Kustrzeba Wojcicka, I ^a   Banas, T ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cancer; Midkine; Oesophagus; Squamous cell carcinoma; Tumour marker; Vascular endothelial growth factor C (VEGF C)

Indexed keywords

MIDKINE; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER CELL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LEUKOCYTE COUNT; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 34250788807     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701192470     Document Type: Article

References (25)

1. Bollschweiler, E., Baldus, SE, Schroder, W., Prenzel, K., Gutschow, C., Schneider, PM and Holscher, AH (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy, 38, pp. 149-156.
2. Enzinger, PC and Mayer, RJ (2003) Medical Progress: Esophageal Cancer. New England Journal of Medicine, 349, pp. 2241-2252.
3. Green, FL, Page, DL, Fleming, ID, Fritz, A., Balch, ChM, Haller, DG and Morrow, M. (2002) AJCC Cancer Staging Manual, Springer Verlag, New York
4. Ikematsu, S., Nakagawara, A., Nakamura, Y., Sakuma, S., Wakai, K., Muramatsu, T. and Kadomatsu, K. (2003) Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas. British Journal of Cancer, 88, pp. 1522-1526. neuroblastomas.
5. Kadomatsu, K. and Muramatsu, T. (2004) Midkine and pleiotrophin in neural development and cancer. Cancer Letters, 204, pp. 127-143.
6. Klinger, MH and Jelkmann, W. (2002) Role of blood platelets in infection and inflammation. Journal of Interferon & Cytokine Research, 22, pp. 913-922.
7. Konishi, N., Nakamura, M., Nakaoka, S., Hiasa, Y., Cho, M., Uemura, H., Hirao, Y., Muramatsu, T. and Kadomatsu, K. (1999) Immunohistochemical analysis of midkine expression in human prostate carcinoma. Oncology, 57, pp. 253-257.
8. Krzystek-Korpacka, M., Matusiewicz, M., Grabowski, K., Diakowska, D., Boehm, D., Kustrzeba-Wojcicka, I. and Banas, T. (2006) Immunoenzymatic method for midkine determination in serum. Advances in Clinical & Experimental Medicine, 15, pp. 247-252.
9. Krzystek-Korpacka, M., Matusiewicz, M., Diakowska, D., Grabowski, K., Blachut, K. and Banas, T. (2007) Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Letters, 249, pp. 171-177.
10. Kuwano, H., Kato, H., Miyazaki, T., Fukuchi, M., Masuda, N., Nakajima, M., Fukai, Y., Sohda, M., Kimura, H. and Faried, A. (2005) Genetic alterations in esophageal cancer. Surgery Today, 35, pp. 7-18.
11. Mitsuhashi, A., Suzuka, K., Yamazawa, K., Matsui, H., Seki, K. and Sekiya, S. (2005) Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer, 103, pp. 724-730.
12. Mukai, M., Sato, S., Nakasaki, H., Tajima, T., Saito, Y., Nishiumi, N., Iwasaki, M., Tokuda, Y., Ogoshi, K., Inoue, H. and Makuuchi, H. (2004) Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer. Oncology Reports, 11, pp. 81-84.
13. Muramatsu, T. (2002) Midkine and pleiotrophin: Two related proteins involved in development, survival, inflammation and tumorigenesis. Journal of Biochemistry, 132, pp. 359-371.
14. Natsugoe, S., Mueller, J., Stein, H., Feith, M., Hofler, H. and Siewert, JR (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer, 83, pp. 858-866.
15. Nomiya, T., Nemoto, K., Miyachi, H., Fujimoto, K., Takahashi, C., Takeda, K., Matushita, H., Ogawa, Y., Takai, Y. and Yamada, S. (2002) Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma. Anticancer Research, 22, pp. 2913-2916.
16. Parkin, DM, Bray, F., Ferlay, J. and Pisani, P. (2005) Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians, 55, pp. 74-108.
17. Ren, YJ and Zhang, QY (2006) Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World Journal of Gastroenterology, 12, pp. 2006-2010.
18. Salama, RH, Muramatsu, H., Zhou, P., Okayama, M. and Muramatsu, T. (2006) Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells. Cancer Letters, 233, pp. 16-20.
19. Sato, T., Iizuka, N., Hamamoto, Y., Yoshino, S., Abe, T., Takeda, S., Uchimura, S., Miyamoto, T., Sei, F., Hamada, K., Yamada-Okabe, H. and Oka, M. (2006) Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. International Journal of Oncology, 28, pp. 1043-1055.
20. Shimada, H., Nabeya, Y., Mastubara, H., Okazumi, S., Shiratori, T., Shimizu, T., Aoki, T., Shuto, K., Akutsu, Y. and Ochiai, T. (2006) Prediction of lymph node status in patients with superficial esophageal carcinoma: Analysis of 160 surgically resected cancers. American Journal of Surgery, 91, pp. 250-254.
21. Shimada, H., Nabeya, Y., Okazumi, S., Matsubara, H., Kadomatsu, K., Muramatsu, T., Ikematsu, S., Sakuma, S. and Ochiai, T. (2003) Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer. Oncology Report, 10, pp. 411-414.
22. Shimada, H., Nabeya, Y., Tagawa, M., Okazumi, S., Matsubara, H., Kadomatsu, K., Muramatsu, T., Ikematsu, S., Sakuma, S. and Ochiai, T. (2003) Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Science, 94, pp. 628-632.
23. Sobin, LH and Wittekind, Ch (2002) TNM Classification of Malignant Tumors, Jon Wiley & Sons, Hoeboken, New Jersey
24. Soulie, P., Heroult, M., Bernard-Pierrot, I., Caruelle, D., Oglobine, J., Barritault, D. and Courty, J. (2004) Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients. Cancer Detection & Prevention, 28, pp. 319-324.
25. Tamura, M., Oda, M., Tsunezuka, Y., Matsumoto, I., Kawakami, K., Ohta, Y. and Watanabe, G. (2004) Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest, 126, pp. 342-346.